Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12196481rdf:typepubmed:Citationlld:pubmed
pubmed-article:12196481lifeskim:mentionsumls-concept:C0017687lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C0020456lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C0032821lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C0221099lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C1416578lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C1709866lld:lifeskim
pubmed-article:12196481lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:12196481pubmed:issue9lld:pubmed
pubmed-article:12196481pubmed:dateCreated2002-8-28lld:pubmed
pubmed-article:12196481pubmed:abstractTextGenetic factors play an important role in the pathogenesis of type 2 diabetes. The relevance to type 2 diabetes of the common polymorphism Glu23Lys in the potassium inward rectifier 6.2 (KIR6.2) gene is still controversial. The aim of this study was to assess whether this polymorphism influences beta-cell function, alpha-cell function, or insulin action. We therefore studied 298 nondiabetic subjects using an oral glucose tolerance test (OGTT) and 75 nondiabetic subjects using a hyperglycemic clamp (10 mmol/l) with additional glucagon-like peptide (GLP)-1 and arginine stimulation. The prevalence of the Lys allele was approximately 37%, and the Lys allele was associated with higher incremental plasma glucose during the OGTT (P = 0.03, ANOVA). Neither first- nor second-phase glucose-stimulated C-peptide secretion was affected by the presence of the polymorphism; nor were maximal glucose-, GLP-1-, or arginine-induced C-peptide secretion rates; nor was insulin sensitivity (all P > 0.7). However, the relative decrease in plasma glucagon concentrations during the 10 min after the glucose challenge was reduced in carriers of the Lys allele (10 +/- 3% decrease from baseline in Lys/Lys, 18 +/- 2% in Glu/Lys, and 20 +/- 2% in Glu/Glu; P = 0.01, ANOVA). In conclusion, our findings suggest that the common Glu23Lys polymorphism in KIR6.2 is not necessarily associated with beta-cell dysfunction or insulin resistance but with diminished suppression of glucagon secretion in response to hyperglycemia. Our findings thus confirm its functional relevance for glucose metabolism in humans.lld:pubmed
pubmed-article:12196481pubmed:languageenglld:pubmed
pubmed-article:12196481pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12196481pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12196481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12196481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12196481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12196481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12196481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12196481pubmed:statusMEDLINElld:pubmed
pubmed-article:12196481pubmed:monthSeplld:pubmed
pubmed-article:12196481pubmed:issn0012-1797lld:pubmed
pubmed-article:12196481pubmed:authorpubmed-author:MachicaoFaust...lld:pubmed
pubmed-article:12196481pubmed:authorpubmed-author:StumvollMicha...lld:pubmed
pubmed-article:12196481pubmed:authorpubmed-author:TschritterOtt...lld:pubmed
pubmed-article:12196481pubmed:authorpubmed-author:FritscheAndre...lld:pubmed
pubmed-article:12196481pubmed:authorpubmed-author:WeisserMelani...lld:pubmed
pubmed-article:12196481pubmed:authorpubmed-author:HäringHansHlld:pubmed
pubmed-article:12196481pubmed:authorpubmed-author:MaerkerElkeElld:pubmed
pubmed-article:12196481pubmed:authorpubmed-author:TeigelerAnnaAlld:pubmed
pubmed-article:12196481pubmed:authorpubmed-author:HolzwarthMart...lld:pubmed
pubmed-article:12196481pubmed:issnTypePrintlld:pubmed
pubmed-article:12196481pubmed:volume51lld:pubmed
pubmed-article:12196481pubmed:ownerNLMlld:pubmed
pubmed-article:12196481pubmed:authorsCompleteYlld:pubmed
pubmed-article:12196481pubmed:pagination2854-60lld:pubmed
pubmed-article:12196481pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:meshHeadingpubmed-meshheading:12196481...lld:pubmed
pubmed-article:12196481pubmed:year2002lld:pubmed
pubmed-article:12196481pubmed:articleTitleThe prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia.lld:pubmed
pubmed-article:12196481pubmed:affiliationDepartment of Endocrinology, Metabolism and Pathobiochemistry, Medizinische Klinik, Eberhard-Karls-Universität, Tübingen, Germany.lld:pubmed
pubmed-article:12196481pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12196481pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3767entrezgene:pubmedpubmed-article:12196481lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12196481lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12196481lld:entrezgene
lhgdn:association:58264lhgdn:found_inpubmed-article:12196481lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12196481lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12196481lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12196481lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12196481lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12196481lld:pubmed